| Improving heart failure by interval training. | Brage Hoyem Amundsen | 29 Aug 2010 | Heart failure / LV dysfunction |
| Treatment options in mitochondrial diseases. | Ryuichiro Anan | 29 Aug 2010 | Heart failure / LV dysfunction |
| Basic mechanisms. | Saskia Schlossarek | 29 Aug 2010 | Heart failure / LV dysfunction |
| The proteasome and endothelial dysfunction. | Karl Stangl | 29 Aug 2010 | Heart failure / LV dysfunction |
| Proteasome activity in adaptive cardiac growth. | Christophe Depre | 29 Aug 2010 | Heart failure / LV dysfunction |
| Regulation of the endothelial cell cycle by the ubiquitin-proteasome system. | Fabio Martelli | 29 Aug 2010 | Heart failure / LV dysfunction |
| Pathophysiology of volume overload. | Gadi Cotter | 29 Aug 2010 | Heart failure / LV dysfunction |
| Signs, symptoms and markers. | Claudio Rapezzi | 29 Aug 2010 | Heart failure / LV dysfunction |
| Established and novel treatments. | John T Parissis | 29 Aug 2010 | Heart failure / LV dysfunction |
| 2010 focused update of ESC Guidelines on device therapy in heart failure. | Kenneth Dickstein | 29 Aug 2010 | Heart failure / LV dysfunction |
| Epidemiology and pathophysiology. | Stefan Anker | 29 Aug 2010 | Heart failure / LV dysfunction |
| Iron deficiency. | Piotr Ponikowski | 29 Aug 2010 | Heart failure / LV dysfunction |
| Erythropoiesis stimulation: current status. | Marc Pfeffer | 29 Aug 2010 | Heart failure / LV dysfunction |
| The haematologist's view. | Joao Forjaz Lacerda | 29 Aug 2010 | Heart failure / LV dysfunction |
| Diabetic cardiomyopathy. | Clyde Yancy | 29 Aug 2010 | Heart failure / LV dysfunction |
| The impact of impaired glucose tolerance and insulin resistance on patient outcome. | Mamas Mamas | 29 Aug 2010 | Heart failure / LV dysfunction |
| The STAR Heart Study: the acute and long-term effect of intracoronary stem cell transplantation in 191 patients with chronic heart failure | Bodo-Eckehard Strauer | 29 Aug 2010 | Heart failure / LV dysfunction |
| Discussant: The STAR Heart Study: the acute and long-term effect of intracoronary stem cell transplantation in 191 patients with chronic heart failure | Francisco Fernandez-Aviles | 29 Aug 2010 | Heart failure / LV dysfunction |
| Discussant: PEARL HF: Multicenter, randomized, double-blind, placebo-controlled, parallel-group, multiple-dose study to evaluate the effects of RLY5016 in heart failure patients | Henry J Dargie | 29 Aug 2010 | Heart failure / LV dysfunction |
| SHIFT: Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction | Michel Komajda | 29 Aug 2010 | Heart failure / LV dysfunction |
| Discussant: SHIFT: Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction | Inder Anand | 29 Aug 2010 | Heart failure / LV dysfunction |
| Inflammasome formation in the mouse heart during acute myocardial infarction promotes adverse cardiac remodeling | Stefano Toldo | 29 Aug 2010 | Heart failure / LV dysfunction |
| Acutely decompensated chronic ischaemic heart failure with pulmonary congestion. | Marco Metra | 29 Aug 2010 | Heart failure / LV dysfunction |
| Panel discussion. | Alexandre Mebazaa | 29 Aug 2010 | Heart failure / LV dysfunction |
| Acute heart failure with hypotension and renal dysfunction. | Alexandre Mebazaa | 29 Aug 2010 | Heart failure / LV dysfunction |
| What do the Guidelines say? | Jose Lopez-Sendon | 29 Aug 2010 | Heart failure / LV dysfunction |
| Is it a reversible condition? | Mihai Gheorghiade | 29 Aug 2010 | Heart failure / LV dysfunction |
| Myocardial energetics. | Michael P Frenneaux | 29 Aug 2010 | Heart failure / LV dysfunction |
| Role of micronutrients. | John Cleland | 29 Aug 2010 | Heart failure / LV dysfunction |
| Role of macronutrients. | Marco Metra | 29 Aug 2010 | Heart failure / LV dysfunction |
| Gender aspects in heart failure management. | Vera Regitz-Zagrosek | 29 Aug 2010 | Heart failure / LV dysfunction |
| Causes. | Lorenzo Monserrat | 29 Aug 2010 | Heart failure / LV dysfunction |
| New brain natriuretic peptides and adrenomedullin. | Stefan Anker | 29 Aug 2010 | Heart failure / LV dysfunction |
| Extracellular matrix biomarkers. | Burkert Mathias Pieske | 29 Aug 2010 | Heart failure / LV dysfunction |
| New markers of renal dysfunction. | Dirk van Veldhuisen | 29 Aug 2010 | Heart failure / LV dysfunction |
| Putting biomarkers in clinical perspective. | Stephen Gottlieb | 29 Aug 2010 | Heart failure / LV dysfunction |
| SHIFT: Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction | Michel Komajda | 29 Aug 2010 | Heart failure / LV dysfunction |
| Endothelial overexpression of beta-3 adrenergic receptor in rat, a relevant model of heart failure with preserved ejection fraction | Nicolas Piriou | 29 Aug 2010 | Heart failure / LV dysfunction |
| Interleukin-6-deficient mice are resistant to development of cardiomyopathy induced by beta 1-adrenergic receptor | Li-Ping Ma | 29 Aug 2010 | Heart failure / LV dysfunction |
| Hypoalbuminemia is an independent predictor of incident heart failure in community-dwelling older adults without prevalent heart failure | M I Ahmed | 29 Aug 2010 | Heart failure / LV dysfunction |
| Elevated pericardial fluid levels of granulocyte colony-stimulating factor are closely associated with left ventricular remodeling | Shoichi Miyamoto | 29 Aug 2010 | Heart failure / LV dysfunction |
| The role of adiponectin at different stages of atherosclerosis in heart failure: associations with myocardial redox state | Alexios Antonopoulos | 29 Aug 2010 | Heart failure / LV dysfunction |
| Cell therapy for non-ischaemic cardiomyopathy. | Gerd Hasenfuss | 29 Aug 2010 | Heart failure / LV dysfunction |
| Cell therapy for ischaemic cardiomyopathy. | Anthony Mathur | 29 Aug 2010 | Heart failure / LV dysfunction |
| The case of tachycardia. | Michael Boehm | 29 Aug 2010 | Heart failure / LV dysfunction |
| The medical treatment of myocardial dysfunction. | Hiroyuki Tsutsui | 29 Aug 2010 | Heart failure / LV dysfunction |
| Treatment with ventricular assist devices. | Mariell Jessup | 29 Aug 2010 | Heart failure / LV dysfunction |
| Novel non-medical strategies. | Gerhard Hindricks | 30 Aug 2010 | Heart failure / LV dysfunction |
| Ongoing clinical trials. | William Abraham | 30 Aug 2010 | Heart failure / LV dysfunction |
| Renal failure and anaemia. | Marco Metra | 30 Aug 2010 | Heart failure / LV dysfunction |
| Chronic obstructive pulmonary disease. | Gerasimos Filippatos | 30 Aug 2010 | Heart failure / LV dysfunction |
| Diabetes. | Michael Boehm | 30 Aug 2010 | Heart failure / LV dysfunction |
| Atrial fibrillation. | Piotr Ponikowski | 30 Aug 2010 | Heart failure / LV dysfunction |
| EURObservational Research programme. | Luigi Tavazzi | 30 Aug 2010 | Heart failure / LV dysfunction |
| The heart failure Registry: a 'general study'. | Aldo Pietro Maggioni | 30 Aug 2010 | Heart failure / LV dysfunction |
| The ablation atrial fibrillation Registry. A 'sentinel' study. | Josep Brugada Terradellas | 30 Aug 2010 | Heart failure / LV dysfunction |
| The pregnancy in congenital/valvular heart disease Registry. A special 'study'. | Roger Hall | 30 Aug 2010 | Heart failure / LV dysfunction |
| Transcutaneous valve replacement Registry. A 'special' study. | Carlo Di Mario | 30 Aug 2010 | Heart failure / LV dysfunction |
| Abnormal haemodynamics. | Veselin Mitrovic | 30 Aug 2010 | Heart failure / LV dysfunction |
| Fluid retention. | Daniela Pini | 30 Aug 2010 | Heart failure / LV dysfunction |
| Worsening renal function. | Adriaan Voors | 30 Aug 2010 | Heart failure / LV dysfunction |
| Inflammation. | Gadi Cotter | 30 Aug 2010 | Heart failure / LV dysfunction |
| Don't know. | John Cleland | 30 Aug 2010 | Heart failure / LV dysfunction |
| Secretoneurin is a novel peptide increased in the myocardium and circulation in heart failure with cardioprotective properties | Helge Rosjo | 30 Aug 2010 | Heart failure / LV dysfunction |
| Accelerated progression of stress-induced heart failure in mice with a human CPVT mutation | Simon Sedej | 30 Aug 2010 | Heart failure / LV dysfunction |
| Myocardial connective tissue growth factor (CCN2/CTGF) attenuates left ventricular remodeling after myocardial infarction and prevents ischemic heart failure | Jorgen Amundsen Gravning | 30 Aug 2010 | Heart failure / LV dysfunction |
| Circulating microparticles as indicator for vascular damage in peripartum cardiomyopathy | Katrin Walenta | 30 Aug 2010 | Heart failure / LV dysfunction |
| State of the Art - Paradigm shift in heart failure research - Tribute to Helmut Drexler | Michael Boehm | 30 Aug 2010 | Heart failure / LV dysfunction |
| Pain management. | Tiny Jaarsma | 30 Aug 2010 | Heart failure / LV dysfunction |
| Sleep disordered breathing - beware snoring. | Theresa McDonagh | 30 Aug 2010 | Heart failure / LV dysfunction |
| Physical and sexual activity. | Massimo Francesco Piepoli | 30 Aug 2010 | Heart failure / LV dysfunction |
| Serum levels of N-terminal pro-B-type natriuretic peptide and cardiac troponin T predict renal disease progression in patients with diabetes mellitus, anemia, and chronic kidney disease | Akshay Suvas Desai | 30 Aug 2010 | Heart failure / LV dysfunction |
| Serum asymmetric dimethylarginine and 1-year mortality in patients with acute decompensated heart failure and reduced ejection fraction | Michael Zairis | 30 Aug 2010 | Heart failure / LV dysfunction |
| NT-proBNP correlates strongly with ejection fraction measured by MRI in patients treated for ST-elevation myocardial infarction | Nisha Mistry | 30 Aug 2010 | Heart failure / LV dysfunction |
| NT-pro-BNP and cTnT as markers for subclinical early-onset anthracycline-induced cardiotoxicity in children. A prospective study. | Annelies Mavinkurve | 30 Aug 2010 | Heart failure / LV dysfunction |
| Plasma renin activity is a strong and independent predictor of the outcome in heart failure in presence of RAS inhibition. | Mariusz Krzysztof Szymanski | 30 Aug 2010 | Heart failure / LV dysfunction |
| Plasma prolactin concentration reflects clinical status and inflammatory activation in chronic heart failure patients | Dimitrios Farmakis | 30 Aug 2010 | Heart failure / LV dysfunction |
| Should every adult with chronic dyspnoea get brain natriuretic peptide testing? | Ulf Georg Dahlstrom | 30 Aug 2010 | Heart failure / LV dysfunction |
| Immunosuppressive and antiviral therapy. | Heinz-Peter Schultheiss | 30 Aug 2010 | Heart failure / LV dysfunction |
| Exercise. | Pantaleo Giannuzzi | 30 Aug 2010 | Heart failure / LV dysfunction |
| Hormonal treatment. | Ewa Anita Jankowska | 30 Aug 2010 | Heart failure / LV dysfunction |
| Ultrafiltration. | Maria Rosa Costanzo | 30 Aug 2010 | Heart failure / LV dysfunction |
| Prognostic significance of mitral flow derived Doppler indices in a general population with normal systolic function: A prospective population-based chort study. The Tromso Study 1994-2009. | Geir Heggelund | 30 Aug 2010 | Heart failure / LV dysfunction |
| Clinical profile and in-hospital outcomes in patients admitted for heart failure with preserved or reduced ejection fraction: the Epi-Cardio prospective survey | Carlos Tajer | 30 Aug 2010 | Heart failure / LV dysfunction |
| Myocardial fibrosis is associated with diastolic heart failure in hypertensive patients - noninvasive assessment by cardiac magnetic resonance | Yusuke Nakagawa | 30 Aug 2010 | Heart failure / LV dysfunction |
| Inflammation triggers transfidderentiation to myofibroblasts in patients with HFNEF: a trigger for diastolic dysfunction | Dirk Westermann | 30 Aug 2010 | Heart failure / LV dysfunction |
| Myocardial stiffness increased in heart failure regardless of left ventricular ejection fraction | Mi-Seung Shin | 30 Aug 2010 | Heart failure / LV dysfunction |
| Prevalence of heart failure with preserved systolic function in latin america, middle east and africa: results of I-PREFER study | Jose Antonio Magana Serrano | 30 Aug 2010 | Heart failure / LV dysfunction |
| Beta-blockers in elderly patients differentially affect symptoms and myocardial function in systolic vs. diastolic heart failure: results from the CIBIS-ELD trial | Frank Edelmann | 30 Aug 2010 | Heart failure / LV dysfunction |
| Aldosterone inhibitors do not improve survival in systolic heart failure, a propensity scored analysis of the Swedish Heart Failure Registry | Lars Lund | 30 Aug 2010 | Heart failure / LV dysfunction |
| Comparative efficacy of combined therapy with angiotensin converting enzyme inhibitor and angiotensin receptor blocker and direct renin inhibitor in patients with severe chronic heart failure | Liana Tumasyan | 30 Aug 2010 | Heart failure / LV dysfunction |
| Intermittent inotropic infusions for the treatment of refractory end stage heart failure: a randomized clinical study | Michael Bonios | 30 Aug 2010 | Heart failure / LV dysfunction |
| Is there a mortality risk amongst heart failure patients taking beta-2 agonists? | Margaret Bermingham | 30 Aug 2010 | Heart failure / LV dysfunction |
| Novel proteIn therapeutics for chronic systolic heart failure: chronic subcutaneous BNP administration (NICE BNP) | Horng Chen | 30 Aug 2010 | Heart failure / LV dysfunction |
| Desmin expression in cardiomyocytes - a good predictor of development of chronic heart failure. | Agnieszka Pawlak | 30 Aug 2010 | Heart failure / LV dysfunction |
| Atherosclerosis and cardiac remodelling in Obstructive Sleep Apnea as assessed by Cardiovascular Magnetic Resonance | Ilias Kylintireas | 30 Aug 2010 | Heart failure / LV dysfunction |
| Accuracy of cardiovascular magnetic resonance imaging (MRI) in biopsy-proven inflammatory cardiomyopathy | Matthias Frick | 30 Aug 2010 | Heart failure / LV dysfunction |
| Troponin in nonischemic dilated cardiomyopathy: a marker of irreversible myocardial remodeling and fibrosis | Andrea Barison | 30 Aug 2010 | Heart failure / LV dysfunction |
| Clinical and neurohormonal correlates of sexual dysfunction in patients with chronic heart failure | Konstantinos Tsitlakidis | 30 Aug 2010 | Heart failure / LV dysfunction |
| Dosing of neurohormones antagonists. | Massimo Francesco Piepoli | 31 Aug 2010 | Heart failure / LV dysfunction |
| Brain natriuretic peptide guided therapy. | G Michael Felker | 31 Aug 2010 | Heart failure / LV dysfunction |
| What do I do with the drugs when the creatinine is too high? | Adriaan Voors | 31 Aug 2010 | Heart failure / LV dysfunction |
| Should I use statins? | Aldo Pietro Maggioni | 31 Aug 2010 | Heart failure / LV dysfunction |
| Clinical characteristics and in-hospital mortality of acute heart failure: The OFICA study | Damien Logeart | 31 Aug 2010 | Heart failure / LV dysfunction |
| Diagnosis, treatment and outcome of acute heart failure in Africa - results of the THESUS-HF study | Albertino Damasceno | 31 Aug 2010 | Heart failure / LV dysfunction |
| The prevalence of left ventricular systolic dysfunction and AF in 5354 South Asian and African Caribbean subjects: results from the Ethnic-Echocardiographic Heart of England (E-ECHOES) study | Paramjit Gill | 31 Aug 2010 | Heart failure / LV dysfunction |
| Prevalence, causes and risk factors for left ventricular dysfunction and heart failure amongst middle-aged and elderly population in Kenya | Gerald Yonga | 31 Aug 2010 | Heart failure / LV dysfunction |
| Prevalence of heart failure in Turkish adult oopulation: results from Heart fAilure Prevalence and Predictors in TurkeY (HAPPY) study | Muzaffer M Degertekin | 31 Aug 2010 | Heart failure / LV dysfunction |
| Chronic multi-sensor monitoring of heart failure patients predicts acute heart failure decompensation events: results from the MUSIC-Asia study | Inder Anand | 31 Aug 2010 | Heart failure / LV dysfunction |
| Cardiac resynchronisation therapy for any patient with ejection fraction below 30% and QRS over 130 msec.: Pro. | Clyde Yancy | 31 Aug 2010 | Heart failure / LV dysfunction |
| Cardiac resynchronisation therapy for any patient with ejection fraction below 30% and QRS over 130 msec.: Contra. | Mariell Jessup | 31 Aug 2010 | Heart failure / LV dysfunction |
| Implantable cardioverter-defibrillator for any patient with low left-ventricular ejection fraction below 30%.: Pro. | Maurizio Gasparini | 31 Aug 2010 | Heart failure / LV dysfunction |
| Implantable cardioverter-defibrillator for any patient with low left-ventricular ejection fraction below 30%.: Contra. | John Cleland | 31 Aug 2010 | Heart failure / LV dysfunction |
| Heart failure. | Guillaume Jondeau | 31 Aug 2010 | Heart failure / LV dysfunction |
| New science. | Zoltan Papp | 31 Aug 2010 | Heart failure / LV dysfunction |
| New diagnostic and prognostic insights. | Ulf Georg Dahlstrom | 31 Aug 2010 | Heart failure / LV dysfunction |
| Therapeutic news. | Aldo Pietro Maggioni | 31 Aug 2010 | Heart failure / LV dysfunction |
| My top ten papers from the European Journal of Heart Failure 2008/9. | Dirk van Veldhuisen | 31 Aug 2010 | Heart failure / LV dysfunction |
| Cyclic GMP modulators and activators. | Mihai Gheorghiade | 31 Aug 2010 | Heart failure / LV dysfunction |
| Cardiac myosin activators. | Gerd Hasenfuss | 31 Aug 2010 | Heart failure / LV dysfunction |
| Relaxin. | John R Teerlink | 31 Aug 2010 | Heart failure / LV dysfunction |
| Adenosine receptor blockers. | Marco Metra | 31 Aug 2010 | Heart failure / LV dysfunction |
| Non-invasive ventilation. | Josep Masip | 31 Aug 2010 | Heart failure / LV dysfunction |
| Ultrafiltration and peritoneal dialysis. | Alexandre Mebazaa | 31 Aug 2010 | Heart failure / LV dysfunction |
| Counterpulsation. | John Nanas | 31 Aug 2010 | Heart failure / LV dysfunction |
| New ventricular assist devices. | Friedrich Wilhelm Mohr | 31 Aug 2010 | Heart failure / LV dysfunction |
| Implantable monitoring devices. | William Abraham | 31 Aug 2010 | Heart failure / LV dysfunction |
| Epidemiology of risk factors for coronary artery disease and heart failure. | Theresa McDonagh | 31 Aug 2010 | Heart failure / LV dysfunction |
| Hypertension. | Faiez Zannad | 31 Aug 2010 | Heart failure / LV dysfunction |
| Dislipidemia. | John Kjekshus | 31 Aug 2010 | Heart failure / LV dysfunction |
| Diabetes. | John McMurray | 31 Aug 2010 | Heart failure / LV dysfunction |
| Mitral regurgitation. | Ottavio Alfieri | 31 Aug 2010 | Heart failure / LV dysfunction |
| Myocardial constraint in dilated cardiomyopathy. Do results fulfill expectations? | Raffaele Bonifazi | 31 Aug 2010 | Heart failure / LV dysfunction |
| Surgical ventricular remodelling? | Timothy Gardner | 31 Aug 2010 | Heart failure / LV dysfunction |
| Ventricular assist device. | Martin Strueber | 31 Aug 2010 | Heart failure / LV dysfunction |
| Rate control: which drugs? | Harry Crijns | 01 Sep 2010 | Heart failure / LV dysfunction |
| Pulmonary vein isolation: for which patients? | Philippe Mabo | 01 Sep 2010 | Heart failure / LV dysfunction |
| Other electrical treatment. | Jean-Yves Le Heuzey | 01 Sep 2010 | Heart failure / LV dysfunction |
| Prevention of stroke. | Harald Darius | 01 Sep 2010 | Heart failure / LV dysfunction |
| Differential impact of sodium levels on mortality risk in heart failure | Nikolas Deubner | 01 Sep 2010 | Heart failure / LV dysfunction |
| Prognostic value of osteoprotegerin in chronic heart failure: the GISSI-HF trial | Ragnhild Roysland | 01 Sep 2010 | Heart failure / LV dysfunction |
| Ultrasound lung comets as prognostic determinant in heart disease | Luna Gargani | 01 Sep 2010 | Heart failure / LV dysfunction |
| No impact of atrial fibrillation on mortality risk in optimally treated heart failure patients | Arnljot Tveit | 01 Sep 2010 | Heart failure / LV dysfunction |
| Tubular damage and outcome in chronic heart failure | Kevin Damman | 01 Sep 2010 | Heart failure / LV dysfunction |
| Interaction between blood pressure values, renal function and prognosis in heart failure patients with normal and depressed left ventricular ejection fraction. Results from the MAGGIC Meta-Analysis. | Lilian Grigorian | 01 Sep 2010 | Heart failure / LV dysfunction |
| Acute impairement of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary edema | Andrei Dumitru Margulescu | 01 Sep 2010 | Heart failure / LV dysfunction |
| Durable effects of chronic vagus nerve stimulation for treatment of chronic heart failure: Extended follow-up of the CardioFit Multicenter Pilot Study | Harry Crijns | 01 Sep 2010 | Heart failure / LV dysfunction |
| Is the cut-off LVEF value of <= 35% for prophylactic ICD implantation after STEMI stable over time | David Altmann | 01 Sep 2010 | Heart failure / LV dysfunction |
| Left ventricular longitudinal systolic dysfunction and impaired atrio-ventricular synchrony are the main mechanisms of acute hypertensive pulmonary edema | Andrei Dumitru Margulescu | 01 Sep 2010 | Heart failure / LV dysfunction |
| Impact of longitudinal myocardial deformation on the prognosis of chronic heart failure patients. | Julien Nahum | 01 Sep 2010 | Heart failure / LV dysfunction |
| Exercise left ventricular circumferential function identifies response to cardiac resynchronisation therapy in patients with advanced heart failure | Marie Moonen | 01 Sep 2010 | Heart failure / LV dysfunction |
| Medication profile on admission and discharge in acute pulmonary edema and acute decompensated chronic heart failure: An Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF) sub-analysis | Dimitrios Farmakis | 01 Sep 2010 | Heart failure / LV dysfunction |
| Levosimendan and dobutamine have similar potential risk for cardiac arrhythmias during 24 infusion in patients with acute decompensated heart failure | Yuksel Cavusoglu | 01 Sep 2010 | Heart failure / LV dysfunction |
| Target weight guided treatment of acute heart failure using ultrafiltration or usual care: results of a randomized pilot study. | Eugene Chung | 01 Sep 2010 | Heart failure / LV dysfunction |
| The significance of minor myocardial necrosis in patients with acute decompensated heart failure and preserved left ventricular ejection fraction | Michael Zairis | 01 Sep 2010 | Heart failure / LV dysfunction |
| Reduced exercise capacity in type 2 diabetes: left ventricular dysfunction or impaired skeletal muscle perfusion? | Julian Sacre | 01 Sep 2010 | Heart failure / LV dysfunction |
| Differential response of Murf-1 and MafBX expression in the skeletal muscle to training interventions in heart failure patients | Stephan Gielen | 01 Sep 2010 | Heart failure / LV dysfunction |
| Intensive glycaemic control has no impact on the risk of heart failure in diabetic: evidence from a 27202 patients meta-analysis. | Davide Castagno | 01 Sep 2010 | Heart failure / LV dysfunction |
| Impaired exercise capacity and metabolic imbalance, the role of adiponectin in progression and symptomatic status of chronic heart failure | Tibor Szabo | 01 Sep 2010 | Heart failure / LV dysfunction |
| Iron deficiency and exercise intolerance in patients with systolic chronic heart failure | Ewa Anita Jankowska | 01 Sep 2010 | Heart failure / LV dysfunction |
| Effect of folic acid supplementation in patients with chronic heart failure | Mathias Wolfrum | 01 Sep 2010 | Heart failure / LV dysfunction |
| Extensive pre-operative assessment of heart failure patients with left ventricular aneurysm: head-to-head comparison between real-time three-dimensional echocardiography and magnetic resonance imaging | Nina Ajmone Marsan | 01 Sep 2010 | Heart failure / LV dysfunction |
| Predictors of adverse remodeling after surgical ventricular reconstruction | Serenella Castelvecchio | 01 Sep 2010 | Heart failure / LV dysfunction |
| Stem cells and tissue engineering associated with polyester mesh support device for ischemic cardiomyopathy | Juan Carlos Chachques | 01 Sep 2010 | Heart failure / LV dysfunction |
| Myocardial Assistance by Grafting a New Upgraded bioartificial Myocardium (MAGNUM Trial): clinical results at 2 years | Juan Carlos Chachques | 01 Sep 2010 | Heart failure / LV dysfunction |
| Percutaneous tissue engineered pulmonary valved stent implantation: mid-term study | Anja Metzner | 01 Sep 2010 | Heart failure / LV dysfunction |
| Hemodynamic improvement upon levosimendan treatment in low cardiac output syndrome patients following coronary artery bypass graft | Henning Lemm | 01 Sep 2010 | Heart failure / LV dysfunction |
| Proton pump inhibitors do not interact with the immunosuppressant enteric-coated mycophenolate sodium | Sieglinde Kofler | 01 Sep 2010 | Heart failure / LV dysfunction |
| Circulating anti-heart autoantibodies are non-invasive markers of high cellular rejection burden in heart transplantation | Alida Lp Caforio | 01 Sep 2010 | Heart failure / LV dysfunction |
| Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality | Maria Angeles Castel Lavilla | 01 Sep 2010 | Heart failure / LV dysfunction |
| Exercise performance with pulsatile and continuous-flow left ventricular assist devices in patients with end-stage heart failure | Ralph Pruijsten | 01 Sep 2010 | Heart failure / LV dysfunction |
| Long-term mechanical ventricular support in children : a single-center french experience | Sylvie Di Filippo | 01 Sep 2010 | Heart failure / LV dysfunction |
| Cardiac transplant using allografts from older donors: results of a single-center | Maria Angeles Castel Lavilla | 01 Sep 2010 | Heart failure / LV dysfunction |
| Direct comparison of the prognostic value of serial BNP and NT-proBNP measurements in patients with heart failure | Gerard Linssen | 01 Sep 2010 | Heart failure / LV dysfunction |
| The added value of depression to NYHA class: the results of the QDF study | Paola Di Giulio | 01 Sep 2010 | Heart failure / LV dysfunction |
| Prognostic value of discharge levels of N-terminal pro-brain natriuretic peptide in 1301 patients admitted for acutely decompensated heart failure: a European Collaborative Study | Khibar Salah | 01 Sep 2010 | Heart failure / LV dysfunction |
| Iron deficiency predicts unfavourable outcome in patients with systolic chronic heart failure | Ewa Anita Jankowska | 01 Sep 2010 | Heart failure / LV dysfunction |
| Oral glucose tolerance testing in an outpatient heart failure clinic reveals a high proportion of undiagnosed diabetic patients with an adverse prognosis | Michael Egstrup | 01 Sep 2010 | Heart failure / LV dysfunction |
| May men and women have different predictors for cardiac mortality in chronic heart failure? | Guliz Kozdag | 29 Aug 2010 | Heart failure / LV dysfunction |
| Prognostic value of cancer antigen 125 (ca 125) in mild to moderate heart failure patients | Enrico Vizzardi | 29 Aug 2010 | Heart failure / LV dysfunction |
| Prevalence of myocardial fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance | Paul Kirk | 29 Aug 2010 | Heart failure / LV dysfunction |
| Diabetes mellitus worsens cardiac remodeling in aged spontaneously hypertensive rats | Katashi Okoshi | 29 Aug 2010 | Heart failure / LV dysfunction |
| Left ventricular sphericity as an early indicator of decompensated hypertrophy in experimental aorta regurgitation | Meliza Roscani | 29 Aug 2010 | Heart failure / LV dysfunction |
| Micro RNAs could play key roles in progression of left ventricular diastolic dysfunction involved in myocardial fibrosis in patients with heart failure | Hideo Izawa | 29 Aug 2010 | Heart failure / LV dysfunction |
| The relationship between CA 125 levels and right ventricular function in patients with chronic obstructive pulmonary disease | Omer Uz | 29 Aug 2010 | Heart failure / LV dysfunction |
| Subclinical myocardial dysfunction in patients with Friedreich ataxia and normal left ventricular ejection fraction | Chantal Dedobbeleer | 29 Aug 2010 | Heart failure / LV dysfunction |
| Metabolomics and heart failure: a new and promising scientific approach | Christian Cadeddu Dessalvi | 29 Aug 2010 | Heart failure / LV dysfunction |
| Clinical significance of clinical scenarios in acute heart failure syndromes: A report from ATTEND registry | Naoki Sato | 29 Aug 2010 | Heart failure / LV dysfunction |
| Association of plasma B-type natriuretic peptide levels with shunt size in young adults with atrial septal defect | Omer Uz | 29 Aug 2010 | Heart failure / LV dysfunction |
| Circulating timp1 and beta2microglobulin as biomarkers of cardio-renal remodelling in heart failure and in the athlete's heart | Annamaria Vianello | 29 Aug 2010 | Heart failure / LV dysfunction |
| Clinical utility of intrathoracic impedance monitoring in patients with implanted devise | Yoshimitsu Soga | 29 Aug 2010 | Heart failure / LV dysfunction |
| Cardiovascular abnormalities in the Low IGF-1 Syndrome: insights from the TOSCA project | Alberto Maria Marra | 29 Aug 2010 | Heart failure / LV dysfunction |
| Inflammation results in increased levels of NT-proBNP and an increased NT-proBNP/BNP ratio | Li-Ping Ma | 29 Aug 2010 | Heart failure / LV dysfunction |
| Left ventricular function assessed by global strain in Hodgkin's lymphoma long-term survivors after adjuvent anthracycline chemotherapy-- a two-dimensional speckle tracking echocardiographic study. | Huey-Ru Tsai | 29 Aug 2010 | Heart failure / LV dysfunction |
| Myocardial longitudinal deformation in thalassemic patients. An Echocardiographic 2D-Speckle tracking study | Luana Sirugo | 29 Aug 2010 | Heart failure / LV dysfunction |
| Association between QRS duration and increased LV end systolic volume and early LV dysfunction in patients at high cardiovascular risk in the ONTARGET/TRANSCEND cardiac MRI sub-study | Ralph Stewart | 29 Aug 2010 | Heart failure / LV dysfunction |
| Metalloproteinase-9 serum levels and restrictive diastolic filling pattern as major predictors of outcome in patients with ischemic cardiomyopathy | Frank Lloyd Dini | 29 Aug 2010 | Heart failure / LV dysfunction |
| Increased visceral and pericardial fat mass is associated with early diastolic dysfunction | Ricardo Fontes Carvalho | 29 Aug 2010 | Heart failure / LV dysfunction |
| Impact of nutritional status on middle term mortality of patients with heart failure. | Daniel Garcia Fuertes | 29 Aug 2010 | Heart failure / LV dysfunction |
| Identification of histone modification and associated histone deacetylase sensitivity in conserved cis-regulatory domains of the abra gene | Nelson Chong | 30 Aug 2010 | Heart failure / LV dysfunction |
| Heart-type fatty acid binding protein in the detection of sub-clinical myocardial damage in patients with heart failure: comparison with high-sensitive troponin I | Manuela Cabiati | 30 Aug 2010 | Heart failure / LV dysfunction |
| Inhibition of nitric oxide synthase normalizes force- and velocity-dependent indices of cardiac contractility in diabetic rats: roles of nitrosative stress and myosin heavy chain isoform switch | Dong Feng Yeih | 30 Aug 2010 | Heart failure / LV dysfunction |
| Soluble epoxide hydrolase inhibition attenuates cardiac remodelling post-myocardial infarction | Andrew Kompa | 30 Aug 2010 | Heart failure / LV dysfunction |
| The severity of regional myocardial dysfunction is not affected by cardiomyocyte apoptosis in non-ischemic heart failure. | Tommaso Prescimone | 30 Aug 2010 | Heart failure / LV dysfunction |
| Supraventricular tachyarrhythmias occurring after orthotopic heart transplantation: a 16-year single center experience. | Alex Bittner | 30 Aug 2010 | Heart failure / LV dysfunction |
| Influenza H1N1 in pediatric heart transplants | Maria Del Carmen Vazquez Alvarez | 30 Aug 2010 | Heart failure / LV dysfunction |
| Heart failure-induced myosin heavy chain changes in rat diaphragm muscle are not related to gene expression of myogenic regulatory factors | Aline Regina Ruiz Lima | 30 Aug 2010 | Heart failure / LV dysfunction |
| Acute and chronic effects of flavanoid-rich cacao on endothelial function in patients with chronic heart failure | Isabella Sudano | 30 Aug 2010 | Heart failure / LV dysfunction |
| Myogenic regulatory factors and myostatin/follistatin expression in heart failure-induced skeletal muscle phenotype changes | Ricardo Damatto | 30 Aug 2010 | Heart failure / LV dysfunction |
| Effect of medical therapy on microvascular tissue perfusion in acutely decompensated chronic heart failure | Alexander Lauten | 30 Aug 2010 | Heart failure / LV dysfunction |
| Bacterial DNA, archaeal bodies and complement activation in chronic chagasic cardiopathy | Maria De Lourdes Higuchi | 30 Aug 2010 | Heart failure / LV dysfunction |
| Worsening of renal function in patients with high central venous pressure and left ventricular filling pressure | Massimo Iacoviello | 30 Aug 2010 | Heart failure / LV dysfunction |
| Evaluation of metabolic liver function in patients with chronic heart failure, current knowledge and research perspectives | Filip Malek | 30 Aug 2010 | Heart failure / LV dysfunction |
| Renalase deficiency in heart failure:a novel mechanism underlying circulating catecholamine accumulation | Biao Xu | 30 Aug 2010 | Heart failure / LV dysfunction |
| The blunted muscle vasodilatation during hypoxia in heart failure patients is mediated by sympathetic activation and endothelial dysfunction | Marcelo dos Santos | 30 Aug 2010 | Heart failure / LV dysfunction |
| Cardiopulmonary exercise test for risk assessment of elderly patients with chronic heart failure : independent prognostic role of ventilatory parameters | Laura Gatto | 30 Aug 2010 | Heart failure / LV dysfunction |
| Dopamine agonists and heart failure in patients with Parkinsons disease: a nested case control study on multiple healthcare databases | Mostafa Mokhles | 30 Aug 2010 | Heart failure / LV dysfunction |
| Multimodality approach with coronary flow velocity assessment of left anterior coronary artery by tranthoracic echocardiography and 64-slice computed tomography in patients with unknown heart failure | Fausto Rigo | 30 Aug 2010 | Heart failure / LV dysfunction |
| Incidence and predictors of new developed cardiogenic shock in patients with acute myocardial infarction after successful revascularization | Keun-Ho Park | 30 Aug 2010 | Heart failure / LV dysfunction |
| One-year prognosis in patients with markedly reduced left ventricular function: association with results of endomyocardial biopsy | Aggeliki Gouziouta | 30 Aug 2010 | Heart failure / LV dysfunction |
| Baseline low-density lipoprotein levels and cardiovascular outcomes in patients with acute heart failure after acute myocardial infarction from the Korea acute myocardial infarction registry | Jang Hoon Lee | 30 Aug 2010 | Heart failure / LV dysfunction |
| Antioxidant quercetin reduces oxidative stress and ameliorates myocardial and ventricular function of diabetic rats | Marina Okoshi | 30 Aug 2010 | Heart failure / LV dysfunction |
| SchlaHF register: prevalence of sleep-disordered breathing in German patients with chronic heart failure | Holger Woehrle | 30 Aug 2010 | Heart failure / LV dysfunction |
| Heart failure differentially affects the electrophysiological properties of adjacent heart regions implicated in persistent atrial fibrillation | Lorraine Mackenzie | 30 Aug 2010 | Heart failure / LV dysfunction |
| Effect of carvedilol in patients with or without renal impairment after myocardial infarction:analysis of the carvedilol post-infarct survival control in left ventricular dysfunction (CAPRICORN) study | Davide Castagno | 30 Aug 2010 | Heart failure / LV dysfunction |
| HLA polymorphisms and their role as diagnostic and prognostic marker in patients with dilated cardiomyopathy | Sabine Pankuweit | 30 Aug 2010 | Heart failure / LV dysfunction |
| Relation of left ventricular longitudinal strain analysis by speckle tracking echocardiography and invasively determined left ventricular stroke volume in patients with systolic heart failure | Matteo Cameli | 31 Aug 2010 | Heart failure / LV dysfunction |
| Effects of paclitaxel and carboplatine combination on myocardial mechanical and microvascular functions | Cihan Altin | 31 Aug 2010 | Heart failure / LV dysfunction |
| The use of tissue doppler imaging to detect myocardial dysfunction prior to conventional measures of left ventricular function in patients undergoing breast cancer treatment with trastuzumab | Daniel Augustine | 31 Aug 2010 | Heart failure / LV dysfunction |
| Chronic right ventricular apical pacing does not always have harmful impacts on left ventricular function | Yasuhiko Hori | 31 Aug 2010 | Heart failure / LV dysfunction |
| Comparison of haemodynamics, neurohumoral response and clinical outcome on prolonged infusion without a loading dose between levosimendan and milrinone in patients with decompensated heart failure | Ioannis Kanonidis | 31 Aug 2010 | Heart failure / LV dysfunction |
| NTproBNP, a non-invasive tool for assessment of patients with pulmonary arterial hypertension: correlations with echocardiographic and cardiopulmonary exercise testing parameters. | Angela Flox Camacho | 31 Aug 2010 | Heart failure / LV dysfunction |
| Positive effects of exogenous nitric oxide on left ventricular function during acute hemodilution with low viscosity plasma expander | Surapong Chatpun | 31 Aug 2010 | Heart failure / LV dysfunction |
| Acute elevation of serum triglycerides increases left ventricular contractility measured by 2D strain and strain rate | Thomas H Marwick | 31 Aug 2010 | Heart failure / LV dysfunction |
| The benefits of statin treatment on cardiac function in chronic heart failure: a meta-analysis of randomized controlled trials | Shuning Zhang | 31 Aug 2010 | Heart failure / LV dysfunction |
| Assessment of systolic and diastolic function in asymptomatic subjects using ambulatory monitoring with acoustic cardiography | Roger Dillier | 31 Aug 2010 | Heart failure / LV dysfunction |
| Pre-systolic preparation for left ventricular ejection is impaired in heart failure | Jan E Engvall | 31 Aug 2010 | Heart failure / LV dysfunction |
| Role of hemodialytic therapy on left venatirular mechanical dyssynchrony in patients with end-stage renal failure quantified by speckle-tracking strain imaging | Kaoru Dohi | 31 Aug 2010 | Heart failure / LV dysfunction |
| Quantifying cardiac stress and myocardial necrosis in acute heart failure with preserved and reduced left ventricular ejection fraction | Corinna Heinisch | 31 Aug 2010 | Heart failure / LV dysfunction |
| Preserved left ventricular early diastolic and systolic reserve during supine bicycle exercise in patients with heart transplantation | Lene Annette Rustad | 31 Aug 2010 | Heart failure / LV dysfunction |
| Screening of asymptomatic left ventricular diastolic dysfunction (ALVDD) in a high-risk population enrolled in a primary care setting through ECG and natriuretic peptides. The DAVID-BERG study | Mauro Gori | 31 Aug 2010 | Heart failure / LV dysfunction |
| Extended duration of aldosterone blockade fails to improve diastolic dysfunction over the effects of blood pressure in patients with heart failure and normal ejection fraction | Thomas H Marwick | 31 Aug 2010 | Heart failure / LV dysfunction |
| The association of different measures of obesity with left ventricular diastolic dysfunction in the general population | Marcus Dorr | 31 Aug 2010 | Heart failure / LV dysfunction |
| The cardioprotective effects of probucol against trastuzumab and anthracycline mediated cardiotoxicity | Jonathan Walker | 31 Aug 2010 | Heart failure / LV dysfunction |
| Beta blockers, statins and recommended doses of ACE-I improve survival in non-randomized patients with heart failure. A propensity score analysis of the Norwegian Heart Failure Registry. | Jonathan De Blois | 31 Aug 2010 | Heart failure / LV dysfunction |
| Therapy of heart failure in decompensation with direct renin inhibitor and changes in renal function | Nadezda Bylova | 31 Aug 2010 | Heart failure / LV dysfunction |
| Effects of statin treatment on long-term clinical outcomes in chronic heart failure: a meta-analysis of 15 prospective clinical trials | Shuning Zhang | 31 Aug 2010 | Heart failure / LV dysfunction |
| Independent and additive influence of statin and beta-blocker on long-term prognosis in patients with chronic heart failure and preserved systolic function | Karlen Adamyan | 31 Aug 2010 | Heart failure / LV dysfunction |
| Efficacy of statins in patients with acute heart failure after acute myocardial infarction from the Korea acute myocardial infarction registry | Jang Hoon Lee | 31 Aug 2010 | Heart failure / LV dysfunction |
| Serum intact parathyroid hormone reduction predicts re-hospitalization after levosimendan therapy in acute heart failure | Sercan Okutucu | 31 Aug 2010 | Heart failure / LV dysfunction |
| Intravenous bolus administration of nicorandil improves myocardial perfusion in patients with acute ischemic heart failure | Yukichi Tokita | 31 Aug 2010 | Heart failure / LV dysfunction |
| Cardioprotective effect of rosuvastatin on doxorubicin induced left ventricular systolic dysfunction in rats | Yong-Hyun Kim | 31 Aug 2010 | Heart failure / LV dysfunction |
| Renal effects of levosimendan in patients admitted with acute decompensated heart failure | Noemi Bruno | 31 Aug 2010 | Heart failure / LV dysfunction |
| Renal effect of carperitide vs nicorandil in the treatment of acute heart failure syndromes | Kiyotaka Watanabe | 31 Aug 2010 | Heart failure / LV dysfunction |
| Comparison of efficacy and safety of carvedilol and eprosartan therapy in patients with chronic heart failure below and above 70 years | Liana Tumasyan | 31 Aug 2010 | Heart failure / LV dysfunction |
| Levosimendan vs. conventional inotropic therapy in decompensate heart failure. 24 months clinical follow-up. | Dulce Alves Brito | 31 Aug 2010 | Heart failure / LV dysfunction |
| Improvement of cardiac sympathetic nerve activity and ventricular function in patients with left ventricular (LV) systolic dysfunction after beta-blocker therapy | Benedetta Fontanella | 31 Aug 2010 | Heart failure / LV dysfunction |
| Economic evaluation of Levosimendan treatment in patients with acute heart failure | Noemi Bruno | 31 Aug 2010 | Heart failure / LV dysfunction |
| Spironolactone reduces mortality rate without changing left ventricular remodeling in spontaneously hypertensive rats | Marcelo Cezar | 31 Aug 2010 | Heart failure / LV dysfunction |
| The use of levosimendan during b-blocker uptitration in patients with chronic heart failure | Ioannis Kanonidis | 31 Aug 2010 | Heart failure / LV dysfunction |
| Optimalization of heart failure therapy guided by plasma BNP concentrations | Jan Krupicka | 31 Aug 2010 | Heart failure / LV dysfunction |
| Clinical 2-years outcome after intracoronary injection of mononuclear bone marrow stem cells in patients with acute myocardial infarction. | Michal Plewka | 01 Sep 2010 | Heart failure / LV dysfunction |
| Impact of obesity on the risk of developing diabetes in patients with heart failure or myocardial infarction | Michelle Schmiegelow | 01 Sep 2010 | Heart failure / LV dysfunction |
| Low cost educational intervention in heart failure patients - does it make difference ? | Tomasz Rywik | 01 Sep 2010 | Heart failure / LV dysfunction |
| Women with heart failure have better survival than men with heart failure irrespective of aetiology and ejection fraction. Results of an individual patient meta-analysis | Iain B Squire | 01 Sep 2010 | Heart failure / LV dysfunction |
| Prognosis value of venous central oxygen saturation in acute decompensated heart failure with cardiogenic shock | Romain Gallet | 01 Sep 2010 | Heart failure / LV dysfunction |
| The prognostic factors of complete and partial reverse remodelling | Bettina Ancsin | 01 Sep 2010 | Heart failure / LV dysfunction |
| Health-related quality of life is better prognostic predictor than NYHA functional class in elderly patients after a heart failure admission | Carlos Rodriguez Pascual | 01 Sep 2010 | Heart failure / LV dysfunction |
| The change in mitral regurgitation and its correlation with left ventricular reverse remodeling and survival in ischemic and non-ischemic chronic heart failure | Noemi Nyolczas | 01 Sep 2010 | Heart failure / LV dysfunction |
| Does minor troponin i elevation have a prognostic value in patients with acute heart failure? | Celine Goeminne | 01 Sep 2010 | Heart failure / LV dysfunction |
| Proprotional pulse amplitude, a simple non-invasive parameter with high prognostic power in advanced heart failure. Therapeutic implications. | Miklos Dekany | 01 Sep 2010 | Heart failure / LV dysfunction |
| Beta trace protein, cystatin C and prognosis in acutely destabilized heart failure | Sergio Manzano Fernandez | 01 Sep 2010 | Heart failure / LV dysfunction |
| Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study | Pieter Kamphuisen | 01 Sep 2010 | Heart failure / LV dysfunction |
| Role of blood urea nitrogen variations in patients with chronic heart failure | Alessandra Manerba | 01 Sep 2010 | Heart failure / LV dysfunction |
| Prevalence and short-term implications of reverse remodeling in dilated cardiomyopathy | Michael Arad | 01 Sep 2010 | Heart failure / LV dysfunction |
| Long-term effects of music therapy on patients with heart failure and acute myocardial infarction after previous revascularization; 8-year experience | Predrag Mitrovic | 01 Sep 2010 | Heart failure / LV dysfunction |
| Left ventricular sphericity is a predictor of prognosis in patients with acute decompensated heart failure | Shinichi Okino | 01 Sep 2010 | Heart failure / LV dysfunction |
| Analysis of renal dysfunction's prognostic validity in chronic heart failure | Lyudmyla Khorunzha | 01 Sep 2010 | Heart failure / LV dysfunction |
| Impact of glomerular filtration rate on urinary BNP and NT-proBNP levels in heart failure | Jose Miguel Rivera Otero | 01 Sep 2010 | Heart failure / LV dysfunction |
| Detrended Fluctuation Analysis (DFA) of heartbeat time series and a1 exponent predicts total mortality in heart failure patients | Petros Arsenos | 01 Sep 2010 | Heart failure / LV dysfunction |
| The effect of direct vasodilator use on the accuracy and applicability of Seattle Heart Failure Model | Barna Szabo | 01 Sep 2010 | Heart failure / LV dysfunction |
| Changes in diastolic function with SVR and CABG by cardiac magnetic resonance | Gopal Ghimire | 29 Aug 2010 | Heart failure / LV dysfunction |
| N-Terminal pro brain naturetic peptide correlates with increased left atrial filling pressures in patients with carcinoid disease | C K L Wong | 29 Aug 2010 | Heart failure / LV dysfunction |
| Segmental diastolic dysfunction of left ventricular wall in patients with 50% coronary artery stenosis | Ri-Ichiro Kakihara | 29 Aug 2010 | Heart failure / LV dysfunction |
| The potential role of oxidative stress, inflammatory and coagulation parameters in the development of diastolic dysfunction in patients with hypertension | Zsuzsanna Szelenyi | 29 Aug 2010 | Heart failure / LV dysfunction |
| Metformin is associated with improved diastolic function measured by echocardiographic tissue Doppler imaging in diabetes patients. | Charlotte Andersson | 29 Aug 2010 | Heart failure / LV dysfunction |
| Predictive impact of baseline plasma renin activity levels on long term clinical outcomes in japanese patients | Keiji Inoue | 29 Aug 2010 | Heart failure / LV dysfunction |
| Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up | Rafaela Ramirez Rodriguez | 29 Aug 2010 | Heart failure / LV dysfunction |
| Correlation of ST2 with IL6 and B-type natriuretic peptide in asymptomatic heart failure patients. | Elrasheed Omer | 29 Aug 2010 | Heart failure / LV dysfunction |
| Evaluation of brain natriuretic peptide (BNP) role as prognostic factor for cardiovascular outcomes in patients undergoing non-cardiac surgery | Laura Magrini | 29 Aug 2010 | Heart failure / LV dysfunction |
| Natriuretic peptide receptors A and C: sequencing and cardiac mRNA expression in normal and heart failure pigs. | Manuela Cabiati | 29 Aug 2010 | Heart failure / LV dysfunction |
| Extension of oedema and myocardial necrosis evaluated by cardiac magnetic resonance in acute myocarditis - impact on biomarkers and ventricular function | Joao Silva Marques | 29 Aug 2010 | Heart failure / LV dysfunction |
| Cardio renal syndrome patients revealed more neurohormonal and inflammatory activity respect to patients with chronic heart failure. | Alberto Palazzuoli | 29 Aug 2010 | Heart failure / LV dysfunction |
| Serum carbohydrate antigen 125 in patients with severe aortic stenosis and preserved ejection fraction | Bogdan Alexandru Popescu | 29 Aug 2010 | Heart failure / LV dysfunction |
| Is late gadolinium enhancement by cardiac magnetic resonance really helpful for risk stratification in stable patients with dilated cardiomyopathy ? | Marie Fertin | 29 Aug 2010 | Heart failure / LV dysfunction |
| Prognostic value of the left and right atrial functional parameters in dilated cardiomyopathy with severe chronic heart failure | Karlen Adamyan | 29 Aug 2010 | Heart failure / LV dysfunction |
| Obesity in heart failure patients: the paradox continues in the long-term follow-up | Elisabet Zamora | 29 Aug 2010 | Heart failure / LV dysfunction |
| Comparative and combined prognostic value of red blood cell distribution width and brain natriuretic peptides in acutely decompensated chronic heart failure patients | Liana Tumasyan | 29 Aug 2010 | Heart failure / LV dysfunction |
| Change in health-related quality of life and mortality in very old patients with heart failure | Carlos Rodriguez Pascual | 29 Aug 2010 | Heart failure / LV dysfunction |
| Blood urea nitrogen (BUN) predicts all-cause mortality in chronic stable heart failure in addition to plasma Nt-proBNP and troponin T | Rudolf Jarai | 29 Aug 2010 | Heart failure / LV dysfunction |
| Chronic furosemide use and survival in patients with heart failure secondary to left ventricular systolic dysfunction | Frank Lloyd Dini | 29 Aug 2010 | Heart failure / LV dysfunction |
| What is the best marker of cardiorenal syndrome in acute heart failure? a prospective hospital cohort study | Cristiana Paulo | 29 Aug 2010 | Heart failure / LV dysfunction |